Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (381-390 of 568) with videos related to

Pageof 57
Sort By:
Medicine|June 29, 2017
Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohortsBenjamín Fernández-Gutiérrez, Pedro P Perrotti, Javier P Gisbert, et al.
Journal of Crohn'S & Colitis|November 20, 2025
Benefit-Risk Profile of Upadacitinib: Exploratory Post Hoc Analysis of Phase 2b/3 Studies in Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseSeverine Vermeire, Jean-Frederic Colombel, Silvio Danese, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 casesIván Guerra, Alicia Algaba, José Lázaro Pérez-Calle, et al.
The American Journal of Gastroenterology|March 17, 2018
Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control studyJavier Molina-Infante, Carolina Gutierrez-Junquera, Edoardo Savarino, et al.
The American Journal of Gastroenterology|December 23, 2008
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter studyCarme Loras, Cristina Saro, Ferràn Gonzalez-Huix, et al.
Journal of Clinical Gastroenterology|June 1, 2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patientsJavier P Gisbert, Angeles Pérez-Aisa, Fernando Bermejo, et al.
Nutrients|January 5, 2021
Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease MonitoringEmilio J Laserna-Mendieta, María José Casanova, Ángel Arias, et al.
Journal of Clinical Gastroenterology|December 9, 2014
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapyCarlos Castaño-Milla, María Chaparro, Cristina Saro, et al.
British Journal of Clinical Pharmacology|February 18, 2024
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registryJuliana Salazar, Esther Garcia-Planella, Agnès Fernández-Clotet, et al.
The American Journal of Gastroenterology|November 6, 2020
Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical TrialMaría Chaparro, Jordi Gordillo, Eugeni Domènech, et al.
Pageof 57

Showing results (381-390 of 568) with videos related to

Sort By:
Pageof 57
Medicine|June 29, 2017
Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohortsBenjamín Fernández-Gutiérrez, Pedro P Perrotti, Javier P Gisbert, et al.
Journal of Crohn'S & Colitis|November 20, 2025
Benefit-Risk Profile of Upadacitinib: Exploratory Post Hoc Analysis of Phase 2b/3 Studies in Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseSeverine Vermeire, Jean-Frederic Colombel, Silvio Danese, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 casesIván Guerra, Alicia Algaba, José Lázaro Pérez-Calle, et al.
The American Journal of Gastroenterology|March 17, 2018
Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control studyJavier Molina-Infante, Carolina Gutierrez-Junquera, Edoardo Savarino, et al.
The American Journal of Gastroenterology|December 23, 2008
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter studyCarme Loras, Cristina Saro, Ferràn Gonzalez-Huix, et al.
Journal of Clinical Gastroenterology|June 1, 2012
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patientsJavier P Gisbert, Angeles Pérez-Aisa, Fernando Bermejo, et al.
Nutrients|January 5, 2021
Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease MonitoringEmilio J Laserna-Mendieta, María José Casanova, Ángel Arias, et al.
Journal of Clinical Gastroenterology|December 9, 2014
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapyCarlos Castaño-Milla, María Chaparro, Cristina Saro, et al.
British Journal of Clinical Pharmacology|February 18, 2024
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registryJuliana Salazar, Esther Garcia-Planella, Agnès Fernández-Clotet, et al.
The American Journal of Gastroenterology|November 6, 2020
Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical TrialMaría Chaparro, Jordi Gordillo, Eugeni Domènech, et al.
Pageof 57